Constellation Pharmaceuticals, Inc. (CNST) Social Stream

Constellation Pharmaceuticals, Inc. (CNST): $33.99

0.02 (+0.06%)

POWR Rating

Component Grades








Add CNST to Watchlist
Sign Up

Featured Post From StockTwits About CNST

$CNST New SEC Filing: 8-K Delisting Emp Changes - CONSTELLATION PHARMACEUTICALS INC (0001434418) July 15

Item 2.01 Completion of Acquisition or Disposition of Assets. As previously disclosed, on June 2, 2021, Constellation Pharmaceuticals, Inc., a Delaware corporation ("Constellation"), entered into an Agreement and Plan of Merger ("Merger Agreement") with MorphoSys AG, a German stock corporation (Aktiengesellschaft) ("MorphoSys"), and MorphoSys Development Inc., a Delaware corporation and an indirect wholly owned subsidiary of MorphoSys ("Purchaser"). Pursuant to the Merger Agreement, and upon the terms and subject to the conditions thereof, on June 16, 2021, Purchaser commenced a tender offer (the "Offer") to purchase all of the outstanding shares (the "Shares") of common stock, par value $0. (...)
MarketNewswire, published July 15, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!